Beam Therapeutics Inc. Annual Operating Income (Loss) in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Beam Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • Beam Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$100M, a 175% decline year-over-year.
  • Beam Therapeutics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$416M, a 135% decline year-over-year.
  • Beam Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$416M, a 135% decline from 2023.
  • Beam Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$176M, a 47.9% increase from 2022.
  • Beam Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$338M, a 13.8% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$416M -$239M -135% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$176M +$162M +47.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$338M +$54M +13.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 -$392M -$260M -196% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$133M -$57.6M -76.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$75.2M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.